#Targetome
Monocrotaline's reactive metabolite covalently modifies platelet IP receptor and PTEN, driving pulmonary hypertension; selexipag and rosiglitazone counteract vascular remodeling in rats.
Details: https://www.maxapress.com/article/doi/10.48130/targetome-0026-0048
#PyrrolizidineAlkaloids